Found 123 matching trials
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia PHASE2 Dyslipidemia is an independent risk factor for cardiovascular events. Stati...
Show More Location
the first affiliated hospital of Harbin medical university
Learn More & Join Trial
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial PHASE4 Investigators will study whether immediate statin treatment after the onset...
Show More Location
Hyogo collage of Medicine
Learn More & Join Trial
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial NA Advanced kidney disease with it's associated heart and blood vessel problem...
Show More Location
St. Paul's Hospital
Learn More & Join Trial
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography PHASE4 The study is a prospective, open-label, randomized, single-center study inv...
Show More Location
Beijing Anzhen Hospital
Learn More & Join Trial
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) NA Statins are the cornerstone of cardiovascular disease (CVD) prevention thro...
Show More Location
Korea University ANAM Hospital
Learn More & Join Trial
Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients N/A Ageing is characterized by physiological changes, which can impact drug pha...
Show More Location
Universitätsspital Basel
Learn More & Join Trial
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I) PHASE3 Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Show More Location
Investigational Site Number 840857
Learn More & Join Trial
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE) PHASE3 Primary Objective:
To provide participants with severe hypercholesterolemi...
Show More Location
Investigational Site Number 040001
Learn More & Join Trial
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health PHASE2 What if midlife women, who are inherently at an increased risk for future c...
Show More Location
University of Colorado-School of Medicine
Learn More & Join Trial
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS NA The study is prospective, open-label, randomized, single-center study invol...
Show More Location
Samara Regional Cardiology Dispansery
Learn More & Join Trial